In Puerto Rico, costs send pharma packing

Poor Puerto Rico. Pharmaceuticals firms are shutting down plants in the U.S. territory, eliminating some 3,000 jobs. Reasons for the closures include Big Pharma's worldwide restructuring, Puerto Rico's expiring tax breaks and high utility bills. Already, Teva Pharmaceuticals, GlaxoSmithKline, Schering-Plough, Watson Pharmaceuticals and Bristol-Myers Squibb have either shuttered facilities or announced plans to do so.

Local lawmakers could remedy the situation by offering new industrial tax breaks to replace an IRS provision that expired last year, but they've been unable to agree on a new approach.

- read this report for more

Related Article:
GSK plant closure begins 5,000 job cuts. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.